Chinese Traditional and Herbal Drugs
|
2025, 56(2): 487-498
Maleimide-modified limonin nanoparticles: Preparation, characterization and its oral pharmacokinetics study
Full
CHEN Yongshun1, YANG Bin2
Affiliations
1 Shangqiu Medical College, Shangqiu 476000, China;
2 Guangxi Medical University, Nanning 530021, China
doi: 10.7501/j.issn.0253-2670.2025.02.012
Outline
Objective To prepare maleimide-modified limonin nanoparticles (Mal-Lim-NPs), characterize its physicochemical properties, and study its oral pharmacokinetic behavior. Methods Single factor experiments combined with Box-Behnken response surface design method (BBD-RSM) was used to gain optimal prescriptions of Mal-Lim-NPs, and its lyophilized powder was prepared. Crystal form of limonin in lyophilized powder of Mal-Lim-NPs was analyzed by X-ray powder diffraction (XRPD), and microscopic appearance was observed by transmission electron microscope (TEM). Solubility and drug release rate of Mal-Lim-NPs in pH 2.0, 5.0, 6.8 phosphate buffers (PBS) were determined. SD rats in each group were administered intragastrically with limonin and Mal-Lim-NPs, respectively, blood drug concentration-time curve was plotted, and main pharmacokinetic parameters was also calculated. Results Optimal prescriptions of Lin-Mal-NP: Mal-PEG-PLA to limonin dosage ratio was 7.5:1, water phase volume was 35 mL and ultrasonic time was 13 min. Average envelopment efficiency, drug loading, particle size and ζ potential were (81.63 ±1.30)%, (9.32 ±0.24)%, (171.56 ±6.63) nm and (−16.60 ±0.92) mV, respectively. The crystalline state of limonin maybe changed in Mal-Lim-NPs lyophilized powder. Microcosmic appearance of Mal-Lim-NPs was still nearly spherical after dissolved by water. The release behavior of Mal-Lim-NPs in pH 2.0, 5.0, 6.8 PBS were in accordance with Weibull model. The tmax of Mal-Lim-NPs delayed to (2.61 ±0.40) h, t1/2 was increased to (6.73 ±1.54) h, Cmax and AUC0—t, AUC0—¥ were increased to 4.01-fold and 5.65, 5.89-fold, respectively. Conclusion Mal-Lim-NPs changed the pharmacokinetic behavior of limonin in vivo and significantly increased the oral absorption, which laid foundation for the following research.
limonin
/
nanoparticles
/
maleimide-modified
/
Box-Behnken response surface design method
/
release in vitro
/
oral pharmacokinetics
陈永顺, 杨斌.
马来酰亚胺修饰的柠檬苦素纳米粒的制备、表征及其口服药动学研究.
中草药,
2025
, 56
(2)
: 487
-498
.
DOI: 10.7501/j.issn.0253-2670.2025.02.012
CHEN Yongshun, YANG Bin.
Maleimide-modified limonin nanoparticles: Preparation, characterization and its oral pharmacokinetics study[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(2)
: 487
-498
.
DOI: 10.7501/j.issn.0253-2670.2025.02.012
Year 2025 volume 56 Issue 2
47
11
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.02.012
- Receive Date:2024-07-08
- Online Date:2026-11-13